(Q34342186)

1 August 2017

1 reference

title

Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

I Grivicich

1

1 reference

1 August 2017

D R Mans

series ordinal

2

1 reference

1 August 2017

G J Peters

series ordinal

3

1 reference

1 August 2017

G Schwartsmann

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Brazilian Journal of Medical and Biological Research

1 August 2017

published in

1 reference

1 August 2017

volume

34

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

1087-1103

1 reference

Fluorouracil: biochemistry and pharmacology

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Clinical relevance of biochemical modulation of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Potential of Xeloda in colorectal cancer and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

CPT-11 in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Irinotecan therapy in adults with recurrent or progressive malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

The current status of camptothecin analogues as antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Irinotecan in the treatment of colorectal cancer: clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Oxaliplatin: a review of preclinical and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Oxaliplatin: a new agent for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2001000900001

10.1590/S0100-879X2001000900001

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference